Skip to main content
Livermore
Livermore
ZHEN

ARS Pharmaceuticals, Inc.

SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671858

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.

Q2 2025 vs. Q1 2025

How the institutions holding ARS Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of SPRY: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders1842188+6
Shares76.2M60.9K84.5M+8.36M (+11.0%)
Value$958.9M$765.7K$1.48B+$516.9M (+53.9%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to SPRY in Q2 2025
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,728,000$30.2M0.05%
Southpoint Capital Advisors LP1,709,069$29.8M0.75%
Next Century Growth Investors LLC622,823$10.9M0.84%
Driehaus Capital Management LLC464,030$8.10M0.06%
First Trust Advisors LP340,119$5.94M0.00%
Pictet Asset Management Holding SA234,841$4.27M0.00%
Avidity Partners Management LP140,000$2.44M0.49%
Hussman Strategic Advisors, Inc.105,000$1.83M0.42%
Universal- Beteiligungs- und Servicegesellschaft mbH101,679$1.77M0.00%
Coastal Bridge Advisors, LLC87,025$1.52M0.13%
Boothbay Fund Management, LLC75,458$1.32M0.04%
Principal Financial Group Inc55,446$967.5K0.00%
Alps Advisors Inc53,000$924.9K0.01%
Aquatic Capital Management LLC48,688$849.6K0.02%
Sit Investment Associates Inc40,350$704.0K0.02%
Bamco Inc40,000$698.0K0.00%
Allianz Asset Management GmbH36,600$638.7K0.00%
Belpointe Asset Management LLC17,323$302.3K0.01%
American Capital Advisory, LLC13,413$234.1K0.12%
Camden Capital, LLC10,000$174.5K0.02%
RiverPark Advisors, LLC5,703$99.5K0.06%
Dauntless Investment Group, LLC2,569$44.8K0.21%
Jones Financial Companies LLLP1,335$24.3K0.00%
MCF Advisors LLC723$12.6K0.00%
Essential Partners LLC57$9950.00%
Larson Financial Group LLC32$5580.00%
Principal Securities, Inc.17$2970.00%
EverSource Wealth Advisors, LLC6$1050.00%

Sold out (22)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of SPRY in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Advisor Resource Council249,230$3.14M
Trexquant Investment LP100,769$1.27M
DAFNA Capital Management LLC95,290$1.20M
Squarepoint Ops LLC76,824$966.4K
Dark Forest Capital Management LP56,553$711.4K
Simplex Trading, LLC44,092$554.0K
Verition Fund Management LLC27,681$348.2K
Corebridge Financial, Inc.24,109$303.3K
HRT Financial LP23,845$299.0K
Twinbeech Capital LP21,700$273.0K
Capula Management Ltd20,791$261.6K
CIBC Private Wealth Group, LLC20,000$246.6K
Engineers Gate Manager LP18,583$233.8K
TFG Advisers LLC12,291$154.6K
Quadrature Capital Ltd10,974$138.1K
CIBC World Markets Corp10,920$137.4K
Two Sigma Investments, LP10,771$135.5K
Quadrant Capital Group LLC347$4.37K
Coldstream Capital Management Inc70$881
CoreCap Advisors, LLC41$516
Parallel Advisors, LLC38$478
Stephens Consulting, LLC30$378

Not filed for Q2 2025 yet (2)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SPRY in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Kodai Capital Management LP60,111$756.2K
Lindbrook Capital, LLC758$9.54K